Free Trial

DXC Technology (DXC) Competitors

DXC Technology logo
$17.15 +0.17 (+1.00%)
Closing price 03:58 PM Eastern
Extended Trading
$17.10 -0.04 (-0.26%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DXC vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, HQY, and WPP

Should you be buying DXC Technology stock or one of its competitors? The main competitors of DXC Technology include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), and WPP (WPP). These companies are all part of the "business services" industry.

DXC Technology vs.

Rentokil Initial (NYSE:RTO) and DXC Technology (NYSE:DXC) are both business services companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation, community ranking and profitability.

Rentokil Initial has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, DXC Technology has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.

DXC Technology has a consensus price target of $21.29, indicating a potential upside of 24.11%. Given DXC Technology's higher possible upside, analysts clearly believe DXC Technology is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rentokil Initial
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
DXC Technology
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

DXC Technology received 406 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 61.16% of users gave DXC Technology an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Rentokil InitialOutperform Votes
5
35.71%
Underperform Votes
9
64.29%
DXC TechnologyOutperform Votes
411
61.16%
Underperform Votes
261
38.84%

Rentokil Initial has higher earnings, but lower revenue than DXC Technology. DXC Technology is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rentokil Initial$5.44B2.12$473.93M$1.5115.09
DXC Technology$13.09B0.24$91M-$0.42-40.83

In the previous week, DXC Technology had 7 more articles in the media than Rentokil Initial. MarketBeat recorded 12 mentions for DXC Technology and 5 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.72 beat DXC Technology's score of 1.03 indicating that Rentokil Initial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rentokil Initial
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
DXC Technology
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Rentokil Initial has a net margin of 0.00% compared to DXC Technology's net margin of -0.57%. DXC Technology's return on equity of 20.70% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Rentokil InitialN/A N/A N/A
DXC Technology -0.57%20.70%4.87%

Rentokil Initial pays an annual dividend of $0.66 per share and has a dividend yield of 2.9%. DXC Technology pays an annual dividend of $0.84 per share and has a dividend yield of 4.9%. Rentokil Initial pays out 43.7% of its earnings in the form of a dividend. DXC Technology pays out -200.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DXC Technology is clearly the better dividend stock, given its higher yield and lower payout ratio.

9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 96.2% of DXC Technology shares are owned by institutional investors. 0.5% of DXC Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

DXC Technology beats Rentokil Initial on 12 of the 21 factors compared between the two stocks.

Remove Ads
Get DXC Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DXC vs. The Competition

MetricDXC TechnologyData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$3.10B$3.97B$24.28B$19.75B
Dividend YieldN/A3.39%2.80%3.75%
P/E Ratio-40.8367.8743.2634.05
Price / Sales0.24633.052,346.1028.57
Price / Cash1.7933.7434.6117.54
Price / Book0.956.096.424.63
Net Income$91M$42.75M$735.89M$1.02B
7 Day Performance-1.01%1.39%1.68%1.12%
1 Month Performance-7.53%-3.84%49,593.11%-1.07%
1 Year Performance-16.83%12.91%52,548.49%7.08%

DXC Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DXC
DXC Technology
2.9115 of 5 stars
$17.15
+1.0%
$21.29
+24.1%
-17.0%$3.10B$13.09B-40.83130,000Positive News
RTO
Rentokil Initial
2.2845 of 5 stars
$22.18
+1.4%
N/A-25.2%$11.20B$5.44B14.6962,900Positive News
ALLE
Allegion
4.602 of 5 stars
$127.42
+0.6%
$138.33
+8.6%
-2.6%$10.99B$3.77B18.6811,000Positive News
FTAI
FTAI Aviation
3.9122 of 5 stars
$107.21
+2.8%
$173.67
+62.0%
+75.8%$10.99B$1.73B-1,071.9740
CART
Maplebear
3.9781 of 5 stars
$40.67
+5.4%
$50.52
+24.2%
+9.0%$10.76B$3.38B27.303,380Positive News
ULS
UL Solutions
1.7202 of 5 stars
$52.34
+0.2%
$51.45
-1.7%
N/A$10.48B$2.87B32.3115,233News Coverage
Positive News
MEDP
Medpace
4.1484 of 5 stars
$326.46
+0.5%
$381.44
+16.8%
-19.1%$9.95B$2.11B25.855,900Analyst Upgrade
News Coverage
Positive News
STN
Stantec
2.2705 of 5 stars
$83.63
+1.4%
N/A-2.9%$9.54B$7.50B38.0128,000Positive News
BILI
Bilibili
1.9386 of 5 stars
$22.28
+3.9%
$21.11
-5.2%
+81.8%$9.23B$26.83B-49.5112,300Positive News
Gap Down
HQY
HealthEquity
3.2484 of 5 stars
$100.80
+3.5%
$112.92
+12.0%
+13.4%$8.74B$1.15B92.483,150Analyst Forecast
News Coverage
WPP
WPP
2.4345 of 5 stars
$40.27
+1.0%
N/A-15.1%$8.69B$14.74B6.75114,732
Remove Ads

Related Companies and Tools


This page (NYSE:DXC) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners